The 329 remaining studies were evaluated in detail and 77 studies that all analyzed GFAP expression levels or patterns in astrocytoma patient material of grade I, grade II, grade III, or grade IV (WHO classification of the respective year) were finally included. The gene discussed is GFAP; the disease is astrocytoma (excluding glioblastoma).